Concepedia

Lei Shu

LS

Statistics

Publications

27

Citations

1.8K

H-Index

20

Active since

2006

Affiliations

Nanjing Medical University(Current)

China Pharmaceutical University

Second Affiliated Hospital of Nanjing Medical University

Jiangsu Province Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

Lei Shu is an author at Nanjing Medical University specializing in medicine, pharmacy, and drug design.

ORCID

Publications per year

2006–2024

27

Publications

27

SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice

James Palacino, Susanne E. Swalley, Cheng Song et al. · Nature Chemical Biology · 2015 · 428 citations

, , +12

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

Lei Shu, Changming Niu, Ruyou Li et al. · Stem Cell Research & Therapy · 2020 · 317 citations · Full text

, , +17

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease

Laurent Peyrin‐Biroulet, J. Casey Chapman, Jean‐Frédéric Colombel et al. · New England Journal of Medicine · 2024 · 160 citations · Full text

, , +13

Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA)

Atwood K. Cheung, Brian Hurley, Ryan Kerrigan et al. · Journal of Medicinal Chemistry · 2018 · 132 citations · Full text

, , +17

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

, , +15

1–5 of 27